The Latest Breaking News from Growth

The auto industry is well-positioned for growth, supported by the rising demand for commercial vehicles and the rapid adoption of electric vehicles. While leading auto stocks Rolls-Royce Holdings (RYCEY) and Tesla (TSLA) should benefit from the industry tailwinds, let us predict which will shine in 2024.

With the rising frequency of natural disasters globally and rapid technological advancements, the property and casualty insurance industry is well-positioned to benefit. Considering this, which stock among the two industry leaders, Berkshire Hathaway (BRK.B) and The Allstate Corp (ALL), is better equipped to yield superior returns? Let’s find out….

There are many ways for a company to approach the use of AI. They can integrate it in their products, inform their own strategic business decisions (such as those made in the M&A arena) and they can use it to enhance their customers' experience. But few companies are embracing the…

AI is the overriding investment theme of 2023. Recent polls show that after AI, most of the top terms for investors in 2023 are almost all bond related…can you say inverted yield curve? But on the stock side of things AI has dominated all other news. And two companies that…

The Guardian US today announced that Emilie Harkin has been appointed as Senior Vice President, Growth, responsible for crafting the Guardian US reader revenue plan in partnership with our UK-based global reader revenue team, determining future areas of investment to drive revenue and profitability, and leading the US-based data and…

Ovira is taking the women’s health industry by storm and is on a mission to end the unnecessary suffering of women everywhere. Ovira is growing, and fast. They’re searching for a new member for their Growth team based in Sydney. In this role, you will dive head-first into all things…

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

The rapid technological advancements and strategic government investments are poised to fuel the chip industry’s growth. In this context, let's determine which of the two chip stocks, Infineon Technologies (IFNNY) and Intel Corporation (INTC), holds the potential for better returns. Read on….

fuboTV (FUBO) has a solid topline growth record and has recently raised its guidance. However, its profitability scenario leaves a lot to be desired. Against this backdrop, can FUBO gain momentum in the near term? Let’s look at its financial metrics to gauge its prospects….

Healthcare is considered a reliable defensive sector. So, amid the current uncertain economic landscape, let's determine the more favorable investment option between two prominent pharmaceutical companies, Moderna (MRNA) and Amicus Therapeutics (FOLD). Keep reading.

The software industry braces itself for growth driven by fast-paced digitization. Considering the industry's promising growth trajectory, quality software stocks such as Akamai Technologies (AKAM), Amdocs Limited (DOX), and SolarWinds Corporation (SWI) might be wise portfolio additions today. Read on….